{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:14:12Z","timestamp":1793229252215,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,8,20]]},"DOI":"10.1001\/jama.2019.10517","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T11:30:56Z","timestamp":1566300656000},"page":"622","source":"Crossref","is-referenced-by-count":87,"title":["Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission"],"prefix":"10.1001","volume":"322","author":[{"given":"Alastair J.","family":"Flint","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Mental Health, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnett S.","family":"Meyers","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Weill Medical College of Cornell University and New York Presbyterian Hospital, Westchester Division, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Rothschild","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School and UMass Memorial Health Care, Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Whyte","sequence":"additional","affiliation":[{"name":"Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.","family":"Alexopoulos","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Weill Medical College of Cornell University and New York Presbyterian Hospital, Westchester Division, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew V.","family":"Rudorfer","sequence":"additional","affiliation":[{"name":"National Institute of Mental Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Marino","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Weill Medical College of Cornell University and New York Presbyterian Hospital, Westchester Division, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samprit","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina D.","family":"Pollari","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Weill Medical College of Cornell University and New York Presbyterian Hospital, Westchester Division, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristotle N.","family":"Voineskos","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit H.","family":"Mulsant","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the STOP-PD II Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"joi190079r1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/schbul\/sbt046","article-title":"Challenges in the treatment of major depressive disorder with psychotic features.","volume":"39","author":"Rothschild","year":"2013","journal-title":"Schizophr Bull"},{"key":"joi190079r2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12991-018-0207-1","article-title":"Psychotic (delusional) depression and completed suicide: a systematic review and meta-analysis.","volume":"17","author":"Gournellis","year":"2018","journal-title":"Ann Gen Psychiatry"},{"issue":"4","key":"joi190079r3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4088\/JCP.11r07324","article-title":"Are antipsychotics or antidepressants needed for psychotic depression? a systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.","volume":"73","author":"Farahani","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"joi190079r4","first-page":"CD004044","article-title":"Pharmacological treatment for psychotic depression.","volume":"30","author":"Wijkstra","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"joi190079r5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1503\/cmaj.071068","article-title":"Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials.","volume":"178","author":"Deshauer","year":"2008","journal-title":"CMAJ"},{"issue":"8","key":"joi190079r6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1001\/archgenpsychiatry.2009.79","article-title":"A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).","volume":"66","author":"Meyers","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"joi190079r7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-244X-13-38","article-title":"Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD II.","volume":"13","author":"Flint","year":"2013","journal-title":"BMC Psychiatry"},{"key":"joi190079r9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"joi190079r11","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.biopsych.2006.05.033","article-title":"A delusion assessment scale for psychotic major depression: reliability, validity, and utility.","volume":"60","author":"Meyers","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"3","key":"joi190079r12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1017\/S1041610204000390","article-title":"The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review.","volume":"16","author":"Jorm","year":"2004","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"joi190079r14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"joi190079r15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/acp.1970.45.issue-s212","article-title":"A rating scale for extrapyramidal side effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"joi190079r16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia.","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"issue":"4","key":"joi190079r18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnoses for tardive dyskinesia.","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"joi190079r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acp.1987.76.issue-s334","article-title":"The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients.","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"joi190079r20","first-page":"CD006727","article-title":"Continuation and maintenance treatments for depression in older people.","volume":"11","author":"Wilkinson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"joi190079r22","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure.","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"issue":"7","key":"joi190079r23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.4088\/JCP.v64n0714","article-title":"A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression.","volume":"64","author":"Oquendo","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"joi190079r24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-N","article-title":"Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale.","volume":"41","author":"Miller","year":"1992","journal-title":"Psychiatry Res"},{"issue":"6","key":"joi190079r27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/acp.1983.67.issue-6","article-title":"The hospital anxiety and depression scale.","volume":"67","author":"Zigmond","year":"1983X8","journal-title":"Acta Psychiatr Scand"},{"issue":"25","key":"joi190079r28","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"20","key":"joi190079r29","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"joi190079r30","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2018.","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"joi190079r31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/acp.2010.121.issue-3","article-title":"Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.","volume":"121","author":"Wijkstra","year":"2010","journal-title":"Acta Psychiatr Scand"},{"issue":"9896","key":"joi190079r32","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"joi190079r33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0010-440X(88)90032-6","article-title":"Relapse in delusional depression: a retrospective study of the course of treatment.","volume":"29","author":"Aronson","year":"1988","journal-title":"Compr Psychiatry"},{"issue":"4","key":"joi190079r34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4088\/JCP.v64n0405","article-title":"How long should patients with psychotic depression stay on the antipsychotic medication?","volume":"64","author":"Rothschild","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"joi190079r35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/sltb.2014.44.issue-2","article-title":"Suicide attempts in major depressed patients with personality disorder.","volume":"44","author":"Amore","year":"2014","journal-title":"Suicide Life Threat Behav"},{"key":"joi190079r8","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders: Patient Edition (SCID-I\/P)","author":"First","year":"2001"},{"key":"joi190079r10","volume-title":"Schedule for Affective Disorders and Schizophrenia","author":"Spitzer","year":"1979","edition":"3rd ed"},{"key":"joi190079r13","first-page":"217","volume-title":"Clinical Global Impressions: ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"joi190079r17","first-page":"534","volume-title":"Abnormal Involuntary Movement Scale (AIMS): ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"joi190079r21","volume-title":"Statistical Analysis with Missing Data","author":"Little","year":"2014"},{"key":"joi190079r25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/CBO9780511759024.015","volume-title":"Melancholia: A Disorder of Movement and Mood","author":"Wilhelm","year":"1996"},{"key":"joi190079r26","volume-title":"Delis-Kaplan Executive Function Scale","author":"Delis","year":"2001"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/article-pdf\/322\/7\/622\/17807943\/jama_flint_2019_oi_190079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T11:31:08Z","timestamp":1566300668000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2748508"}},"subtitle":["The STOP-PD II Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,8,20]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.10517","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,20]]}}}